VANCOUVER: Global Wellness Strategies Inc. has signed a binding letter of intent to acquire 100% of with KaleidoUSA, a company focused on myco-dosing and the production of consumer packaged products.

“We are extremely fortunate to welcome Leah Kinkaid and her world famous experts to the Global Wellness family. Being the first company with direct access to multiple manufacturing facilities in both Washington State and Oregon, with their own formulae, processing licenses, and the proprietary extraction technology to produce myco-dosing SKUs across multiple mushroom platforms differentiates KaleidoUSA immediately from its peers with infused CBD and THC functional mushroom consumer products and soon approved psilocybin tinctures in Oregon. This is an exciting acquisition for our shareholders and we will work diligently to sign a definitive agreement with KaleidoUSA after due diligence is completed by our banking committee,” stated Meris Kott, CEO, Global Wellness Strategies Inc.

The due diligence period will last 45 days consummating with the signing of a definitive agreement detailing the exact terms of the deal.

Global agrees to purchase 100% of the rights to the products and IP, formulae created for consumer products for medicinal mushrooms, CBD-infused mushrooms, plus any and all formulas being developed for psilocybin myco-dosing from KaleidoUSA at a value near CDN$2,500,000; the final valuation to be determined during the due diligence period and approved by the board of Global Wellness Strategies Inc.

The Company proposes to raise capital of CDN$2,000,000 to support the continued development of KaleidoUSA projects.

KaleidoUSA‘s production facility in Washington State already CBD licensed, will bring to market pressed pills, effervescents, muscle cream, anti-aging moisturizers, bath bombs and soaps as their first rollout to the consumer-markets globally. The team is already evaluating psilocybin and THC myco-dosing infused consumer packaged products initiatives with clinics in approved jurisdictions internationally.

On January 13, 2021 Global Wellness Strategies Inc. announced that it had partnered with Clarion Holdings of Eugene, Oregon to open one of the first psilocybin consulting incubators in the area. KaleidoUSA will align itself directly with Clarion in Oregon and facilitate submission of a psilocybin license when available.

KaleidoUSA will begin working with Canadian cannabis licensed producers and choose one LP to rollout a full medicinal-mushroom infused CBD product line into Canadian provincial government approved stores. European partners are already in discussions to begin marketing the CBD infused products in countries where approved.

Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products.

The focus of the Company is on global wellness, hemp and CBD, healthcare-related target companies. www.globalwellnessstrategies.com